← Back to TCM Global · All articles
2026-10-30
# Ginseng Extract Powder vs Liquid Extract for Private Label: Which Should You Buy?
For private label programs, ginseng extract powder is the more flexible and lower-risk starting point (MOQs typically 100-500 kg), while liquid extract commands higher retail prices but demands larger MOQs of 5,000-10,000 units and stricter stability controls. With 2026 industry reports showing high-value processed ginseng extracts growing faster than raw material exports, choosing the right format determines your margin structure, shipping costs, and speed to market.
Both start from the same process: hot-water extraction of ginseng root, followed by concentration and standardization to a defined ginsenoside content. The divergence happens at the final step:
| Factor | Ginseng Extract Powder | Liquid Ginseng Extract |
|---|---|---|
| Typical MOQ | 100-500 kg | 5,000-10,000 units |
| Freight efficiency | High (no water weight) | Low (water adds 60-90% of weight) |
| Retail price positioning | Mid (USD 15-40 per SKU) | Premium (USD 25-60 per SKU) |
| Shelf stability | Excellent, 24-36 months | 12-24 months; ambient-stable variants exist |
| Formulation flexibility | Capsules, sachets, gummies, blends | Vials, RTD bottles, honey drinks |
| Quality control complexity | Moderate | High (pH, brix, sediment, microbial) |
Regardless of format, insist on:
According to industry reports, exports of processed ginseng extracts and finished dosages are growing at double-digit rates, while raw root exports grow more slowly and carry thinner margins. This trend favors both formats over raw material — but between the two, powder is capturing more new brand launches due to its low entry cost, while liquid captures more consumer spend per unit. A common 2026 playbook: launch with powder-based capsules in months 1-6, then add a liquid vial line in months 6-12 once demand is proven.
Consider two worked examples that reflect current market quotes. A powder-based capsule program: 300 kg of 10% ginsenoside extract (FOB roughly USD 25-60/kg) plus encapsulation, bottles, and labels lands around USD 10,000-18,000 for a 20,000-40,000 capsule run — retail-ready in 8-10 weeks. A liquid vial program: 10,000 units of 10 ml red ginseng extract vials at FOB USD 0.35-0.90 per unit, plus custom boxes and freight, lands around USD 18,000-35,000 with a 12-16 week timeline including stability work.
The decision framework many 2026 buyers use: start with powder if capital is below USD 25,000, if your channel is e-commerce-first, or if you want subscription-friendly capsules; start with liquid if you have USD 30,000+, if your channel is retail or gifting, and if your supplier has proven filling lines. Both routes work — what fails is starting liquid on a powder budget, which usually ends with an underfilled first order and a stalled launch.
Some large factories can, but most specialize. Verify a supplier's actual filling line capacity and stability-testing capability before assuming they can do liquid; many powder suppliers outsource filling, which adds 2-4 weeks of lead time and a quality-control gap.
No. Potency depends on ginsenoside standardization, not physical form. A 30% ginsenoside powder is more concentrated than most liquid extracts, which typically contain 10-30% solids overall. Compare COA values per dose, not per format.
Powder-based products usually deliver faster cash flow (lower upfront investment of roughly USD 5,000-20,000 for a first run), while liquid products deliver higher revenue per order but need USD 20,000-50,000 to reach viable MOQs. Match the format to your capital, not just your ambition.